Blog
RSS FeedPosted by Michael Wonder on 28 Jun 2019
Recommendations made by the PBAC - May 2019 intracycle meeting
28 June 2019 - The Department of Health has published an update of the outcomes from the May 2019 PBAC ...
Posted by Michael Wonder on 21 Jun 2019
Price disclosure 2019 October cycle outcomes summary
21 June 2019 - The summary of price disclosure price reductions for the 2019 October Cycle has now been published on ...
Posted by Michael Wonder on 28 May 2019
UK refuses to back 'game-changing' resolution on drug pricing
28 May 2019 - Global agreement urges governments to share information on actual cost of medicines, with aim of making them ...
Posted by Michael Wonder on 27 May 2019
'You disappointed us': Why is Canada opposing more transparency in drug prices?
25 May 2019 - Pharma industry says high prices are necessary to cover costs. Some nations want to see the data. ...
Posted by Michael Wonder on 27 May 2019
Breast cancer treatments, rare disorders, venlafaxine
27 May 2019 - PHARMAC has published more information on its decisions on the funding of medicines for breast cancer, ...
Posted by Michael Wonder on 21 May 2019
Official Information Act response: adrenaline auto-injector cost utility analysis
20 May 2019 - PHARMAC responds to a request for any cost utility analyses performed by PHARMAC in relation to ...
Posted by Michael Wonder on 21 May 2019
The global battle over high drug prices
21 May 2019 - Western countries, as well as poor ones, are demanding transparency in the cost of drugs. ...
Posted by Michael Wonder on 01 May 2019
PHARMAC sheds a little more light on procedures in savvy political move
1 May 2019 - Steve Maharey has just secured special status on David Clark's Christmas card list. ...
Posted by Michael Wonder on 29 Apr 2019
Proposal to decline inactive applications
29 April 2019 - To help make its decision-making process clearer, PHARMAC is seeking feedback on a proposal to make ...
Posted by Michael Wonder on 29 Apr 2019
PHARMAC proposes to give more clarity about funding decisions
29 April 2019 - An overhaul of PHARMAC’s decision-making process will give better insight into what medicines are - and ...
Posted by Michael Wonder on 01 Apr 2019
1 April 2019 price disclosure confirmed prices
1 April 2019 - Confirmed 1 April 2019 prices resulting from the 2019 April cycle of price disclosure have now been ...
Posted by Michael Wonder on 14 Feb 2019
OIA responses: exploring ways to publish them
14 February 2019 - To support New Zealand's commitment to open government, PHARMAC is exploring ways to publish more of ...
Posted by Michael Wonder on 18 Jan 2019
2019 April price disclosure cycle – indicative prices
18 January 2019 - Indicative 1 April 2019 prices resulting from the 2019 April cycle of price disclosure have now been ...
Posted by Michael Wonder on 15 Dec 2018
Price disclosure 2019 April cycle outcomes summary
14 December 2018 - The summary of price disclosure price reductions for the 2019 April Cycle has now been published. ...
Posted by Michael Wonder on 06 Sep 2018
Is it time for a review of the content in PBAC Public Summary Documents?
7 September 2018 - Important content is either not reported or not reported in a consistent manner. ...